Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis

INTRODUCTION: A phase IV clinical trial confirmed the safety and efficacy of repository corticotropin injection (RCI, Acthar(®) Gel) in patients with refractory rheumatoid arthritis (RA) that was nonresponsive to standard-of-care therapies. The objective of this post hoc analysis was to identify bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Roy, Hayes, Kyle, Ahn, Sung-Woo, Wan, George J., Panaccio, Mary, Karlsson, Daniel, Furst, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964897/
https://www.ncbi.nlm.nih.gov/pubmed/35184268
http://dx.doi.org/10.1007/s40744-022-00429-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964897/
https://www.ncbi.nlm.nih.gov/pubmed/35184268
http://dx.doi.org/10.1007/s40744-022-00429-w

Ejemplares similares